VMP 14057611000001107

Search dm+d | This VMP cannot be matched against our prescribing data.

Name Ranibizumab 2.3mg/0.23ml solution for injection vials
BNF code 1108020ADAAABAB
Virtual Therapeutic Moiety Ranibizumab
Basis of preferred name rINN - Recommended International Non-proprietary
Date of name applicability 30 Sep 2008
Previous name Ranibizumab 2.3mg/0.23ml solution for inection vials
Basis of previous name rINN - Recommended International Non-proprietary
Prescribing status Caution - AMP level prescribing advised
Sugar free
Gluten free
Preservative free
CFC free
Non-availability Actual Products Available
Non-availability status date 14 Oct 2013
Dose form Discrete
Unit dose form size 0.230
Unit dose form units ml
Unit dose unit of measure vial
Virtual Product Ingredient
Ingredient Ranibizumab
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 10.000
Strength value numerator unit mg
Strength value denominator 1.000
Strength value denominator unit ml
Ontology Drug Form & Route
Form & Route solutioninjection.intravitreal
Dose Form
Formulation Solution for injection
Drug Route
Route Intravitreal
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Byooviz 2.3mg/0.23ml solution for injection vials (Biogen Idec Ltd)
Lucentis 2.3mg/0.23ml solution for injection vials (Novartis Pharmaceuticals UK Ltd)
Ongavia 2.3mg/0.23ml solution for injection vials (Teva UK Ltd)
Ranivisio 2.3mg/0.23ml solution for injection vials (Teva UK Ltd)
Ximluci 2.3mg/0.23ml solution for injection vials (Genus Pharmaceuticals Ltd)
Virtual Medicinal Product Packs
Ranibizumab 2.3mg/0.23ml solution for injection vials 1 vial

dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.

Feedback